Eagle Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 309,589 shares of ALNY stock, worth $141 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
309,589
Previous 246,204 25.74%
Holding current value
$141 Million
Previous $59.8 Million 42.35%
% of portfolio
0.51%
Previous 0.33%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$233.81 - $287.01 $14.8 Million - $18.2 Million
63,385 Added 25.74%
309,589 $85.2 Million
Q2 2024

Aug 12, 2024
SELL
$143.31 - $247.0 $1.73 Million - $2.97 Million
-12,044 Reduced 4.66%
246,204 $59.8 Million
Q1 2024

May 09, 2024
SELL
$146.51 - $198.2 $676,436 - $915,089
-4,617 Reduced 1.76%
258,248 $38.6 Million
Q4 2023

Feb 12, 2024
BUY
$151.41 - $196.57 $28,010 - $36,365
185 Added 0.07%
262,865 $50.3 Million
Q3 2023

Nov 13, 2023
BUY
$170.77 - $211.65 $636,118 - $788,396
3,725 Added 1.44%
262,680 $46.5 Million
Q2 2023

Aug 09, 2023
SELL
$185.01 - $212.05 $831,249 - $952,740
-4,493 Reduced 1.71%
258,955 $49.2 Million
Q1 2023

May 08, 2023
SELL
$182.66 - $235.53 $41,098 - $52,994
-225 Reduced 0.09%
263,448 $52.8 Million
Q4 2022

Feb 14, 2023
BUY
$185.53 - $241.31 $28,386 - $36,920
153 Added 0.06%
263,673 $62.7 Million
Q3 2022

Nov 07, 2022
BUY
$138.54 - $232.0 $307,143 - $514,344
2,217 Added 0.85%
263,520 $52.7 Million
Q2 2022

Aug 10, 2022
BUY
$120.42 - $169.29 $646,173 - $908,410
5,366 Added 2.1%
261,303 $38.1 Million
Q1 2022

May 12, 2022
BUY
$127.18 - $173.91 $77,198 - $105,563
607 Added 0.24%
255,937 $41.8 Million
Q4 2021

Feb 11, 2022
BUY
$159.56 - $209.29 $247,158 - $324,190
1,549 Added 0.61%
255,330 $43.7 Million
Q3 2021

Nov 10, 2021
SELL
$169.75 - $207.73 $361,228 - $442,049
-2,128 Reduced 0.83%
253,781 $47.9 Million
Q2 2021

Aug 11, 2021
SELL
$128.63 - $176.89 $32,028 - $44,045
-249 Reduced 0.1%
255,909 $43.4 Million
Q1 2021

May 14, 2021
BUY
$126.83 - $175.69 $1.79 Million - $2.47 Million
14,078 Added 5.82%
256,158 $36.3 Million
Q4 2020

Feb 12, 2021
SELL
$122.97 - $147.0 $2.43 Million - $2.91 Million
-19,794 Reduced 7.56%
242,080 $31.5 Million
Q3 2020

Nov 12, 2020
BUY
$121.19 - $165.49 $6,544 - $8,936
54 Added 0.02%
261,874 $38 Million
Q2 2020

Aug 12, 2020
BUY
$104.21 - $156.44 $27.3 Million - $41 Million
261,820 New
261,820 $38.7 Million

Others Institutions Holding ALNY

# of Institutions
808
Shares Held
115M
Call Options Held
584K
Put Options Held
648K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $56.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email